Search for: "Janssen Pharmaceuticals Inc. "
Results 81 - 100
of 226
Sorted by Relevance
|
Sort by Date
24 Jan 2012, 8:29 am
”Janssen issued this statement:"Janssen Pharmaceuticals, Inc. announced today it has reached a settlement with the State of Texas in ongoing litigation related to sales and marketing of the anti-psychotic prescription medication Risperdal (risperidone).Read more: http://www.philly.com/philly/blogs/phillypharma/Reports-JJ-settles-with-Texas-on-Risperdal-anti-psychotic-drug-case.html#ixzz1kOU05xZ4 [read post]
24 Nov 2009, 1:11 am
Other defendants named in the MDL include Bristol-Myers Squibb Co., Solvay Pharmaceuticals Inc., Watson Pharmaceuticals Inc. and Ortho-McNeil Janssen Pharmaceuticals Inc. [read post]
24 Nov 2009, 1:11 am
Other defendants named in the MDL include Bristol-Myers Squibb Co., Solvay Pharmaceuticals Inc., Watson Pharmaceuticals Inc. and Ortho-McNeil Janssen Pharmaceuticals Inc. [read post]
26 Jun 2013, 6:30 am
(Nasdaq: MYL) announced that it, along with Famy Care Ltd., has entered into a settlement agreement with Janssen Pharmaceuticals Inc. that will resolve patent litigation related to Ortho Tri-Cyclen Lo® Tablets, which are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. [read post]
1 Mar 2013, 6:28 am
(Nasdaq: MYL) announced that it, along with Famy Care Ltd., has entered into a settlement agreement with Janssen Pharmaceuticals Inc. that will resolve patent litigation related to Ortho Tri-Cyclen Lo® Tablets, which are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. [read post]
31 Jan 2013, 7:30 am
(Nasdaq: MYL) announced that it, along with Famy Care Ltd., has entered into a settlement agreement with Janssen Pharmaceuticals Inc. that will resolve patent litigation related to Ortho Tri-Cyclen Lo® Tablets, which are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. [read post]
24 Oct 2014, 7:56 am
Janssen Pharmaceuticals, Inc., No. 3:12-oe-40003, 2014 U.S. [read post]
23 Nov 2015, 8:00 am
Janssen Pharmaceuticals Inc., Johnson & Johnson Company and Johnson Pharmaceutical Research and Development, LLC, No. 130401990, Philadelphia County, Court of Common Pleas (Nov. 11, 2015). [read post]
10 Jul 2017, 3:00 am
Portnoff v Janssen Pharmaceuticals Inc, 2017 WL 708745 (E.D. [read post]
9 Aug 2020, 9:06 am
Food and Drug Administration (FDA), and what its makers, Janssen Pharmaceuticals, Inc. [read post]
6 May 2016, 8:00 am
Related blog posts: $124 Million Penalty to Stand Against the Drug Maker Janssen for the Drug Risperdal $90 Million Settlement Paid by Pharmaceutical Company For Its Unfair and Deceptive Promotion of Diabetes Drug Xarelto Lawsuits are Underway in Multi-district Litigation in the U.S. [read post]
21 Jun 2015, 6:17 pm
Por estas razones, se desestimaron las causas de acción y de igual manera las causas de acción bajo las leyes locales contra Johnson & Johnson Services, Inc., Janssen Cilag Mfg., LLC; Janssen Ortho, LLC. [read post]
15 Jan 2010, 8:00 am
Janssen Pharmaceutica Inc., 2007 WL 2022173 (D.S.C. [read post]
9 Jun 2014, 4:51 am
Johnson & Johnson’s subsidiary Janssen Pharmaceuticals Inc. was the direct manufacturer maker of the Risperdal drug. [read post]
4 Feb 2015, 1:43 pm
These lawsuits also claim that Bayer AG and Janssen Pharmaceuticals Inc., a part of the Johnson & Johnson Company failed to warn doctors and their patients that Xarelto has no antidote to reverse bleeding should significant bleeding events occur in patients. [read post]
13 Jul 2012, 8:02 pm
Griem, Jr. of Loeb & Loeb; Patricia Clarke Lukens, Vice President, Law at Janssen Pharmaceuticals, Inc.; and Michael Perry of the Health Care Division at the Federal Trade Commission will analyze the existing case law and pending cases and legislation, review recent trends in settlements reported to the Federal Trade Commission, and discuss in practical terms how this issue affects the conduct and resolution... [read post]
11 Dec 2015, 8:53 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc., No. 15-3104, slip op. (6th Cir. [read post]
13 Jul 2015, 1:00 pm
Janssen Pharmaceuticals, Inc., 2015 WL 4081909 (Pa. [read post]
23 Feb 2016, 1:53 am
Mark has some ideas about that.* Of Mice and Men: Regeneron v KymabAs David's post on Regeneron Pharmaceuticals Inc v Kymab Ltd & Anor [2016] EWHC 87 (Pat) clearly shows, mice have a very special relation with patent case law. [read post]
21 Jun 2011, 6:00 am
Ortho-McNeil-Janssen Pharmaceuticals Inc. announced that the lot of about 16,000 bottles of 3-milligram Risperdal tablets was shipped out anywhere from August, 2010 and February, 2011. [read post]
